Overview
Cerebellar malformation (Orphanet code 182061) is a broad category of rare congenital structural abnormalities affecting the cerebellum, the part of the brain located at the back of the skull responsible for coordinating movement, balance, posture, and motor learning. This group encompasses a wide spectrum of developmental defects ranging from complete absence of the cerebellum (cerebellar agenesis) to partial underdevelopment (cerebellar hypoplasia), abnormal foliation patterns, and other structural anomalies. Cerebellar malformations may occur in isolation or as part of more complex brain malformation syndromes. The clinical presentation varies considerably depending on the specific type and severity of the malformation. Common symptoms include motor coordination difficulties (ataxia), impaired balance, hypotonia (reduced muscle tone), delayed motor milestones, speech and language difficulties, nystagmus (involuntary eye movements), and in some cases intellectual disability or learning difficulties. Some individuals may also experience tremor, difficulties with fine motor tasks, and problems with eye movement coordination. The severity can range from mild motor clumsiness to profound neurological impairment. Cerebellar malformations can arise from a variety of causes including genetic mutations (both inherited and de novo), chromosomal abnormalities, and prenatal environmental factors such as infections or toxic exposures. The genetic basis is highly heterogeneous, with numerous genes implicated depending on the specific subtype. Diagnosis is typically made through brain magnetic resonance imaging (MRI), often supplemented by genetic testing. There is currently no curative treatment for cerebellar malformations. Management is supportive and multidisciplinary, including physical therapy, occupational therapy, speech therapy, and educational support tailored to the individual's needs. Surgical intervention may be required if associated complications such as hydrocephalus are present.
Variable
Can be inherited in different ways depending on the underlying gene
Neonatal
Begins at or shortly after birth (first 4 weeks)
FDA & Trial Timeline
10 eventsUniversity of California, San Francisco — NA
Columbia University — NA
Sclnow Biotechnology Co., Ltd. — PHASE2
University Hospital, Montpellier — NA
IRCCS Eugenio Medea — NA
Kissei Pharmaceutical Co., Ltd. — PHASE3
University of Colorado, Denver — PHASE2
The First Affiliated Hospital with Nanjing Medical University — PHASE2
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
No FDA-approved treatments are currently listed for Cerebellar malformation.
1 clinical trialare actively recruiting — trials can provide access to cutting-edge therapies.
View clinical trials →Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Cerebellar malformation.
Community
No community posts yet. Be the first to share your experience with Cerebellar malformation.
Start the conversation →Latest news about Cerebellar malformation
Disease timeline:
New recruiting trial: A Study to Learn More About the Long-Term Safety of BIIB141 (Omaveloxolone) in Participants With Friedreich's Ataxia Who Are Prescribed it by Their Own Doctors
A new clinical trial is recruiting patients for Cerebellar malformation
New recruiting trial: Efficacy of Stabilometric Platform to Improve Standing Balance in Patients With Friedreich's Ataxia
A new clinical trial is recruiting patients for Cerebellar malformation
New recruiting trial: Ophthalmological Disorders in Dominant Spinal-cerebellar Ataxias
A new clinical trial is recruiting patients for Cerebellar malformation
New recruiting trial: Effects of Oral Administration of Antrodia Cinnamomea Products for Clinical Symptoms in Spinocerebellar Ataxia Patients
A new clinical trial is recruiting patients for Cerebellar malformation
New recruiting trial: Characterisation of the Cognitive Profile of Patients Suffering From Friedreich's Ataxia
A new clinical trial is recruiting patients for Cerebellar malformation
New recruiting trial: Cycling-Based Priming Coordination Training for Enhancing Ataxia Recovery and Brain Plasticity
A new clinical trial is recruiting patients for Cerebellar malformation
New recruiting trial: The EUROSCA Natural History Study
A new clinical trial is recruiting patients for Cerebellar malformation
New recruiting trial: Study of ARO-ATXN2 Injection in Adults With Spinocerebellar Ataxia Type 2
A new clinical trial is recruiting patients for Cerebellar malformation
New recruiting trial: Electroencephalogram in Patients With Friedreich's Ataxia for the Study of the Structural and Functional Connectome.
A new clinical trial is recruiting patients for Cerebellar malformation
New recruiting trial: A Multiple Ascending Dose Study of DT-216P2 in Patients With Friedreich's Ataxia
A new clinical trial is recruiting patients for Cerebellar malformation
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Cerebellar malformation
What is Cerebellar malformation?
Cerebellar malformation (Orphanet code 182061) is a broad category of rare congenital structural abnormalities affecting the cerebellum, the part of the brain located at the back of the skull responsible for coordinating movement, balance, posture, and motor learning. This group encompasses a wide spectrum of developmental defects ranging from complete absence of the cerebellum (cerebellar agenesis) to partial underdevelopment (cerebellar hypoplasia), abnormal foliation patterns, and other structural anomalies. Cerebellar malformations may occur in isolation or as part of more complex brain ma
At what age does Cerebellar malformation typically begin?
Typical onset of Cerebellar malformation is neonatal. Age of onset can vary across affected individuals.
Are there clinical trials for Cerebellar malformation?
Yes — 1 recruiting clinical trial is currently listed for Cerebellar malformation on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.
Which specialists treat Cerebellar malformation?
25 specialists and care centers treating Cerebellar malformation are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.